Travers, J B <br/><br/>
Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis.  [electronic resource] 

 -  The Journal of clinical investigation  Nov 1999 
 - 1181-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0021-9738 
<br/><br/><label>Standard No.: </label>10.1172/JCI6835  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Animals<br/>Case-Control Studies<br/>Dermatitis, Atopic--immunology<br/>Dermatitis, Contact<br/>Epidermis--anatomy & histology<br/>Exotoxins--immunology<br/>HLA-DR Antigens--immunology<br/>Humans<br/>In Situ Hybridization<br/>Leukocytes, Mononuclear--immunology<br/>Lichen Planus--immunology<br/>Mice<br/>Middle Aged<br/>Patch Tests<br/>Psoriasis--immunology<br/>Staphylococcus--immunology<br/>Streptococcus--immunology<br/>Superantigens--immunology<br/>T-Lymphocytes--immunology<br/>Toxins, Biological--immunology<br/>Tumor Necrosis Factor-alpha--metabolism